Therapeutic Advances in Endocrinology and Metabolism

Papers
(The median citation count of Therapeutic Advances in Endocrinology and Metabolism is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Controversies in the management of active Charcot neuroarthropathy104
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review76
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity52
Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis32
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults25
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review23
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers21
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study21
Update on genetics and epigenetics in metabolic associated fatty liver disease20
Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system20
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease18
Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses17
Pheochromocytoma: a changing perspective and current concepts17
Is there a causal relationship between hypothyroidism and hyponatremia?16
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor16
Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes mellitus16
Diagnostic performance of morning basal serum cortisol for assessing adrenal reserve: a single-center experience from the United Arab Emirates15
Prevalence and associated factors of hyperuricemia among Chinese patients with diabetes: a cross-sectional study15
Retraction notice15
Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric study14
Exploring the weight bias of professionals working in the field of obesity with a mobile IAT: a pilot study14
Immune cell infiltration in the pancreas of type 1, type 2 and type 3c diabetes14
Limitation of the current Lin-Weiss-Bisceglia criteria in predicting poor prognosis in oncocytic adrenocortical neoplasms of uncertain malignant potential and oncocytoma diagnosed by the Lin-Weiss-Bis14
A study looking at how missed somatropin injections affect growth in children with growth hormone deficiency: a plain language summary of publication14
Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective14
Potential of duodenal mucosal resurfacing in achieving glycemic control in Asians with type 2 diabetes13
The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic–pituitary–thyroid axis13
Gender-affirming endocrine care for youth with a nonbinary gender identity13
Temporal patterns of inpatient hypoglycaemia are treatment-dependent12
Bone health in transgender people: a narrative review12
Comparing quality of life in traditional face-to-face visits with a hybrid approach of telemedicine with in-person follow-ups in recent users of advanced closed-loop systems: a randomized controlled c11
Age-related markers and predictors of diabetic kidney disease progression in type 2 diabetes patients: a retrospective cohort study10
The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease10
Thanks to Reviewers9
The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology among persons with diabetes mellitus: a narrative review9
Analysis of vitamin D nutritional status and disease risk factors in patients with subacute thyroiditis9
Timing of osteoporosis therapies following fracture: the current status9
Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions8
Association of body mass index and sarcopenia with osteoporosis: a predictive nomogram model for risk assessment8
Implications of gender-affirming endocrine care for sports participation8
Physical activity among adults with type 2 diabetes mellitus in Jordan: a qualitative study8
Glycogen storage disease type III: a mixed-methods study to assess the burden of disease8
Qualitative evaluation of the symptoms and quality of life impacts of long-chain fatty acid oxidation disorders8
The association between diabetes mellitus and incidence of depressive episodes is different based on sex: insights from ELSA-Brasil7
Prediction of cardiac autonomic neuropathy using a machine learning model in patients with diabetes7
Multi-target gene therapy AUP1602-C to improve healing and quality of life for diabetic foot ulcer patients: a phase I, open-label, dose-finding study7
Effect of bicalutamide on serum total testosterone concentration in transgender adults: a case series7
Association of hyponatremia with bone mineral density and fractures: a narrative review7
Analyzing and evaluating the prevalence and metabolic profile of lean NAFLD compared to obese NAFLD: a systemic review and meta-analysis7
Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome7
Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children’s Hospital of Eastern Ontario grossing protocol6
Association of serum parathyroid hormone within normal range with the prevalence and prognosis among adults with diabetes and prediabetes: insight from NHANES 2003–2006 data6
Multi-omics investigation of prospective therapeutic targets for type 1 diabetes6
Noninsulin antidiabetic prescription patterns in Colombia: a cross-sectional study6
Metabolic-associated fatty liver disease and pregnancy complications: new challenges and clinical perspectives6
Successful management of hypercalcemic crisis by continuous renal replacement therapy with regional citrate anticoagulation and surgery: a case report6
RANKL inhibition: a new target of treating diabetes mellitus?5
HbA1c changes in the first year post-kidney transplant and associated risk factors in a Saudi cohort5
Response to a low-energy meal replacement plan on glycometabolic profile and reverse cardiac remodelling in type 2 diabetes: a comparison between South Asians and White Europeans5
Relationship between total testosterone, sex hormone–binding globulin levels and the severity of non-alcoholic fatty liver disease in males: a meta-analysis5
COVID-19 and the hidden threat of diabetic microvascular complications5
Fertility preservation options for transgender and nonbinary individuals4
Effects of 12-week combined interval running and resistance training on cardiac structure and performance in patients with type 1 diabetes4
Emerging pharmacological treatment options for MAFLD4
Dual-basal-insulin regimen for the management of dawn phenomenon in children with type 1 diabetes: a retrospective cohort study4
Impact of anti-peptic ulcer disease medications on type 2 diabetes mellitus risk in patients with PUD: a population-based retrospective cohort study4
MAFLD: what 2 years of the redefinition of fatty liver disease has taught us3
Incidence and predictors of hyperglycemic emergencies among adult diabetic patients at public hospitals of Sidama Region and Gedeo Zone, Southern Ethiopia: a survival analysis3
Fractures and dislocations of the foot and ankle in people with diabetes: a literature review3
ANDROID and A/G ratio are correlated with sarcopenia among type 2 diabetes patients3
Hyponatraemia in patients on immune checkpoint inhibitors3
Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone3
Perioperative glycemic status is linked to postoperative complications in non-intensive care unit patients with type-2 diabetes: a retrospective study3
Menopause, androgens, and cardiovascular ageing: a narrative review3
Exploring the mechanism of metformin action in Alzheimer’s disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation2
Association of continuous glucose monitoring-derived time in range with major amputation risk in diabetic foot osteomyelitis patients undergoing amputation2
Calcitonin: current concepts and differential diagnosis2
Recent advancement in the treatment of boys and adolescents with hypogonadism2
Hippo/YAP signaling pathway: a new therapeutic target for diabetes mellitus and vascular complications2
A step-by-step guide for the diagnosis and management of hyponatraemia in patients with stroke2
Tolvaptan for the treatment of the syndrome of inappropriate antidiuresis (SIAD)2
Epidemiology of gout – Global burden of disease research from 1990 to 2019 and future trend predictions2
Should we undertake surveillance for HCC in patients with MAFLD?2
Real-world evidence of the use of glucocorticoids for severe COVID-192
Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome2
Excessive or sustained endoplasmic reticulum stress: one of the culprits of adipocyte dysfunction in obesity2
Hip axis length and non-hip cortical fragility fractures in young postmenopausal nonobese Caucasian women2
Factors influencing height gain in children born small for gestational age treated with recombinant growth hormone: what extent is puberty involved?2
1.7141921520233